Jade Biosciences clinical trials
Jade Biosciences is the lead sponsor of 3 current clinical trials in our USA, South Korea, Taiwan, Australia and Germany registers. 3 are recruiting patients now. The most common phase is Phase 1. The drugs named most often in its trials are JADE101. The most-studied condition is Healthy Volunteers (HV).
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Jade Biosciences
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
NCT07541287 · IgA Nephropathy
Drug: JADE101 |
Phase 2 | Recruiting | 2026-05 | USA, South Korea, Taiwan, Australia |
|
A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants
NCT07525947 · Healthy Volunteers (HV)
Drug: JADE101 |
Phase 1 | Recruiting | 2026-05 | USA |
|
A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
NCT07533955 · ClinicalTrials.gov ↗ · Rhematoid Arthritis
|
Phase 1 | Recruiting | 2026-05 | Germany |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Jade Biosciences trials
1 compoundDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Jade Biosciences trials
3 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 2 | 2 |
| Clinical trials in South Korea | 1 | 1 |
| Clinical trials in Taiwan | 1 | 1 |
| Clinical trials in Australia | 1 | 1 |
| Clinical trials in Germany | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Healthy Volunteers (HV)
| Sponsor | Trials |
|---|---|
| Hospital de Clinicas de Porto Alegre | 2 |
| Fortvita Biologics (USA)Inc | 1 |
| Xidian University | 1 |
| Eilean Therapeutics | 1 |
Sponsors with the most current trials registered for this condition.
Questions about Jade Biosciences trials
How many clinical trials does Jade Biosciences sponsor?
Jade Biosciences is the lead sponsor of 3 current trials on ClinicalTrials.gov in our USA, South Korea, Taiwan, Australia and Germany registers, as of the registry sync on 26 October 2026. Completed and withdrawn studies are not counted.
Are Jade Biosciences trials recruiting?
Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Which drugs is Jade Biosciences testing?
Its current trials name 1 drug or biological as interventions. The most frequent are JADE101 (2). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.